Lijuan Ding
Impact in
-
- Viral-associated cancers and disorders
- CAR-T cell therapy research
-
- MicroRNA in disease regulation
Papers in
-
- DNA Repair Mechanisms 2
- Oncology 12
- CAR-T cell therapy research 3
- Cancer Diagnosis and Treatment 3
- Co-authors
- Shudong Wang (2 shared papers)Honglei Ji (1 shared paper)Zheng Xu (1 shared paper)Quan Liu (1 shared paper)Yang Zheng (1 shared paper)Lihua Dong (5 shared papers)He Huang (5 shared papers)Qiang Wang (2 shared papers)
In The Last Decade
Lijuan Ding
33 papers receiving 501 citations
Peers
Comparison fields: 5 of 86
- Oncology 147
- Cancer Research 74
- Genetics 50
- Immunology 77
- Pathology and Forensic Medicine 60
Countries citing papers authored by Lijuan Ding
This map shows the geographic impact of Lijuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Ding more than expected).
Fields of papers citing papers by Lijuan Ding
This network shows the impact of papers produced by Lijuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Ding. The network helps show where Lijuan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lijuan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2015 | 49 | |
| 3 | 2022 | 44 | |
| 4 | 2016 | 34 | |
| 5 | 2015 | 25 | |
| 6 | 2016 | 24 | |
| 7 | 2022 | 23 | |
| 8 | 2023 | 21 | |
| 9 | 2019 | 21 | |
| 10 | 2020 | 19 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 17 | |
| 13 | 2016 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 2024 | 15 | |
| 16 | 2015 | 11 | |
| 17 | 2023 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2014 | 7 | |
| 20 | 2016 | 7 |
About Lijuan Ding
Lijuan Ding is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 505 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), CAR-T cell therapy research (3 papers), Cancer Diagnosis and Treatment (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Research and Treatments (2 papers), Effects of Radiation Exposure (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (147 citations), Cancer Research (74 citations), Genetics (50 citations), Immunology (77 citations) and Pathology and Forensic Medicine (60 citations). Lijuan Ding has collaborated with scholars based in China and Germany. Frequent co-authors include Shudong Wang, Honglei Ji, Zheng Xu, Quan Liu, Yang Zheng, Lihua Dong, He Huang, Qiang Wang, Min Liu and Shudong Wang. Their work appears in journals such as Cell Death Discovery, Oncotarget, Oncology Reports, Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.